Doctors Call On DEA To Reschedule Marijuana For Medical Research Purposes
The American Academy of Pediatrics is requesting that the Drug Enforcement Administration reclassify marijuana as a less harmful substance in order to facilitate research of the substance for medical use, according to a policy statement released Monday.
“The AAP strongly supports research and development of pharmaceutical cannabinoids and supports a review of policies promoting research on the medical use of these compounds,” the AAP statement reads. To that end, the group recommends that the DEA reschedule marijuana from a Schedule I controlled substance to Schedule II.
Under the Controlled Substances Act, the U.S. has five “schedules” for drugs and chemicals that can be used to make drugs. Schedule I is reserved for drugs that the DEA considers to have the highest potential for abuse and no “currently accepted medical use.” Marijuana has been classified as Schedule I for decades, along with other substances like heroin and LSD. While a lower schedule for marijuana would not make it legal, it could ease restrictions on researching the drug.
Hemp Can Save the Planet
- Nevada Athletic Commission considering removing marijuana as a banned substance
- Arkansas medical marijuana commission to allow 32 vendors
- Air Force Loosens Marijuana Restrictions
- Bill Walton wants declassification of marijuana as a Schedule I drug and for President Obama to grant blanket amnesty to offenders so everyone can “move on to the future.”
- D.C. Mayor Says City Won’t Target People Who Smoke Joints At Trump’s Inauguration
Help Support JackHerer.com
If you would like to make a donation, thank you.